Literature DB >> 18279439

Persistent human immunodeficiency virus-1 antigenaemia affects the expression of interleukin-7Ralpha on central and effector memory CD4+ and CD8+ T cell subsets.

F Mercier1, M-R Boulassel, B Yassine-Diab, C Tremblay, N-F Bernard, R-P Sekaly, J-P Routy.   

Abstract

Interleukin (IL)-7 and its receptor (IL-7Ralpha) play important roles in regulating lymphopoiesis. Previous studies have reported that human immunodeficiency virus-1 (HIV-1) viraemia affects the expression of IL-7Ralpha, but its effects on CD4+ and CD8+ T cell memory subsets have not been studied. Using eight-colour flow cytometry, we compared the immunophenotypic patterns of CD4+ and CD8+ T cell subsets expressing IL-7Ralpha and activation markers, as well as circulating IL-7 levels, in three well-defined groups of HIV-1-infected subjects: successfully treated, viraemic and long-term non-progressor (LTNP). Compared with successfully treated and LTNP subjects, viraemic patients had reduced expression of IL-7Ralpha on both CD4+ and CD8+ T cells, particularly on central and effector memory T cell compartments, and substantially elevated expression of activation markers on CD8+ T cell subsets. Circulating IL-7 levels were correlated negatively with the number of CD4+ and CD8+ T cell subsets expressing IL-7Ralpha; these associations were stronger with CD4+ T cell subsets and mainly with central and effector memory cells. The expression of activation markers on CD4+ and CD8+ cell T subsets was not related to circulating IL-7 levels. A strong negative correlation was observed between central memory CD4+ or CD8+ T cells expressing IL-7Ralpha and those expressing activation markers, independently of IL-7 levels. Collectively, these results provide further insight on the role of unsuppressed viral load in disrupting the IL-7/IL-7Ralpha system and contributing to HIV-1 disease progression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18279439      PMCID: PMC2384057          DOI: 10.1111/j.1365-2249.2008.03610.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Changes in immunological and virological parameters in HIV-1 infected subjects following leukapheresis.

Authors:  M R Boulassel; G Spurll; D Rouleau; C Tremblay; M Edwardes; R P Sekaly; R Lalonde; J-P Routy
Journal:  J Clin Apher       Date:  2003       Impact factor: 2.821

2.  Circulating levels of IL-7 but not IL-15, IGF-1, and TGF-beta are elevated during primary HIV-1 infection.

Authors:  M R Boulassel; M Young; J P Routy; R P Sekaly; C Tremblay; D Rouleau
Journal:  HIV Clin Trials       Date:  2004 Sep-Oct

3.  Inverse correlation between IL-7 receptor expression and CD8 T cell exhaustion during persistent antigen stimulation.

Authors:  Karl S Lang; Mike Recher; Alexander A Navarini; Nicola L Harris; Max Löhning; Tobias Junt; Hans Christian Probst; Hans Hengartner; Rolf M Zinkernagel
Journal:  Eur J Immunol       Date:  2005-03       Impact factor: 5.532

4.  Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals.

Authors:  Mirko Paiardini; Barbara Cervasi; Helmut Albrecht; Alagarraju Muthukumar; Richard Dunham; Shari Gordon; Henry Radziewicz; Giuseppe Piedimonte; Mauro Magnani; Maria Montroni; Susan M Kaech; Amy Weintrob; John D Altman; Donald L Sodora; Mark B Feinberg; Guido Silvestri
Journal:  J Immunol       Date:  2005-03-01       Impact factor: 5.422

5.  Influence of RANTES, SDF-1 and TGF-beta levels on the value of interleukin-7 as a predictor of virological response in HIV-1-infected patients receiving double boosted protease inhibitor-based therapy.

Authors:  M R Boulassel; G H R Smith; M D de B Edwardes; M Young; M Klein; N Gilmore; J Macleod; R Leblanc; P René; J Allan; R G Lalonde; J P Routy
Journal:  HIV Med       Date:  2005-07       Impact factor: 3.180

6.  Increased plasma interleukin-7 level correlates with decreased CD127 and Increased CD132 extracellular expression on T cell subsets in patients with HIV-1 infection.

Authors:  Sarah C Sasson; John J Zaunders; Giulia Zanetti; Eleanor M King; Kate M Merlin; Don E Smith; Keith K Stanley; David A Cooper; Anthony D Kelleher
Journal:  J Infect Dis       Date:  2006-01-17       Impact factor: 5.226

7.  IL-7Ralpha expression on CD4+ T lymphocytes decreases with HIV disease progression and inversely correlates with immune activation.

Authors:  Sandra A Koesters; Judie B Alimonti; Charles Wachihi; Lucy Matu; Omu Anzala; Joshua Kimani; Joanne E Embree; Francis A Plummer; Keith R Fowke
Journal:  Eur J Immunol       Date:  2006-02       Impact factor: 5.532

8.  T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis.

Authors:  Jason M Brenchley; Brenna J Hill; David R Ambrozak; David A Price; Francisco J Guenaga; Joseph P Casazza; Janaki Kuruppu; Javaidia Yazdani; Stephen A Migueles; Mark Connors; Mario Roederer; Daniel C Douek; Richard A Koup
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Interleukin-7 levels may predict virological response in advanced HIV-1-infected patients receiving lopinavir/ritonavir-based therapy.

Authors:  M R Boulassel; G H R Smith; N Gilmore; M Klein; T Murphy; J MacLeod; R LeBlanc; J Allan; P René; R G Lalonde; J P Routy
Journal:  HIV Med       Date:  2003-10       Impact factor: 3.180

10.  Phenotypic heterogeneity of antigen-specific CD4 T cells under different conditions of antigen persistence and antigen load.

Authors:  Alexandre Harari; Florence Vallelian; Giuseppe Pantaleo
Journal:  Eur J Immunol       Date:  2004-12       Impact factor: 5.532

View more
  21 in total

1.  Filarial infection modulates the immune response to Mycobacterium tuberculosis through expansion of CD4+ IL-4 memory T cells.

Authors:  Soumya Chatterjee; Carolyn E Clark; Enrico Lugli; Mario Roederer; Thomas B Nutman
Journal:  J Immunol       Date:  2015-02-09       Impact factor: 5.422

2.  Increased CD4+ T cell levels during IL-7 administration of antiretroviral therapy-treated simian immunodeficiency virus-positive macaques are not dependent on strong proliferative responses.

Authors:  Amanda Leone; Mukta Rohankhedkar; Afam Okoye; Alfred Legasse; Michael K Axthelm; Francois Villinger; Michael Piatak; Jeffrey D Lifson; Brigitte Assouline; Michel Morre; Louis J Picker; Donald L Sodora
Journal:  J Immunol       Date:  2010-07-09       Impact factor: 5.422

3.  PLA2G1B is involved in CD4 anergy and CD4 lymphopenia in HIV-infected patients.

Authors:  Julien Pothlichet; Thierry Rose; Florence Bugault; Louise Jeammet; Annalisa Meola; Ahmed Haouz; Frederick Saul; David Geny; José Alcami; Ezequiel Ruiz-Mateos; Luc Teyton; Gérard Lambeau; Jacques Thèze
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

4.  Interleukin-7 receptor signaling is deficient in CD4+ T cells from HIV-infected persons and is inversely associated with aging.

Authors:  Douglas A Bazdar; Magdalena Kalinowska; Scott F Sieg
Journal:  J Infect Dis       Date:  2009-04-01       Impact factor: 5.226

5.  Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants.

Authors:  Paige L Williams; Miguel Marino; Kathleen Malee; Susan Brogly; Michael D Hughes; Lynne M Mofenson
Journal:  Pediatrics       Date:  2010-01-18       Impact factor: 7.124

6.  Dual mechanism of impairment of interleukin-7 (IL-7) responses in human immunodeficiency virus infection: decreased IL-7 binding and abnormal activation of the JAK/STAT5 pathway.

Authors:  Olivier Juffroy; Florence Bugault; Olivier Lambotte; Ivan Landires; Jean-Paul Viard; Loïc Niel; Arnaud Fontanet; Jean-François Delfraissy; Jacques Thèze; Lisa A Chakrabarti
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

7.  Transcriptional regulation of the IL-7Rα gene by dexamethasone and IL-7 in primary human CD8 T cells.

Authors:  Juzer A Kakal; Feras M Ghazawi; Elliott M Faller; Scott M Sugden; Parmvir Parmar; Paul A MacPherson
Journal:  Immunogenetics       Date:  2016-08-19       Impact factor: 2.846

8.  Association of HIV-specific and total CD8+ T memory phenotypes in subtype C HIV-1 infection with viral set point.

Authors:  Wendy A Burgers; Catherine Riou; Mandla Mlotshwa; Pholo Maenetje; Debra de Assis Rosa; Jason Brenchley; Koleka Mlisana; Daniel C Douek; Richard Koup; Mario Roederer; Guy de Bruyn; Salim Abdool Karim; Carolyn Williamson; Clive M Gray
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

9.  HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation.

Authors:  Nicolas Chomont; Mohamed El-Far; Petronela Ancuta; Lydie Trautmann; Francesco A Procopio; Bader Yassine-Diab; Geneviève Boucher; Mohamed-Rachid Boulassel; Georges Ghattas; Jason M Brenchley; Timothy W Schacker; Brenna J Hill; Daniel C Douek; Jean-Pierre Routy; Elias K Haddad; Rafick-Pierre Sékaly
Journal:  Nat Med       Date:  2009-06-21       Impact factor: 53.440

10.  Early Initiation Rather Than Prolonged Duration of Antiretroviral Therapy in HIV Infection Contributes to the Normalization of CD8 T-Cell Counts.

Authors:  Wei Cao; Vikram Mehraj; Benoit Trottier; Jean-Guy Baril; Roger Leblanc; Bertrand Lebouche; Joseph Cox; Cecile Tremblay; Wei Lu; Joel Singer; Taisheng Li; Jean-Pierre Routy; S Vézina; L Charest; M Milne; E Huchet; S Lavoie; J Friedman; M Duchastel; F Villielm; P Côté; M Potter; B Lessard; M A Charron; S Dufresne; M E Turgeon; D Rouleau; L Labrecque; C Fortin; A de Pokomandy; V Hal-Gagné; M Munoz; B Deligne; V Martel-Laferrière; N Gilmore; M Fletcher; J Szabo
Journal:  Clin Infect Dis       Date:  2015-09-08       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.